Announcements

QCR Holdings, Inc. filed a Form 8-K with the SEC on August 24, 2026, disclosing a cash dividend declaration of $0.15 per share of common stock, payable on October 5, 2026 to stockholders of record as of September 18, 2026.

Evolution Metals & Technologies Corp. filed a Form 8-K on August 24, 2026, disclosing the status of convertible debentures issued to YA II PN, Ltd. as of August 23, 2026.

Booz Allen Hamilton Holding Corporation filed a Form 8-K with the SEC on August 24, 2026, disclosing that it had closed its previously announced acquisition of Ultra Electronics Advanced Tactical Systems, Inc. on that same date.

Evolution Metals & Technologies Corp. filed a Form 8-K on August 24, 2026, disclosing that the company has been included on FTSE Russell's preliminary lists of additions to the Russell 3000® Index and the Russell 2000® Index as part of FTSE Russell's third-quarter 2026 …

Apollo Global Management, Inc. filed a Form 8-K on August 24, 2026, disclosing under Item 7.01 (Regulation FD) that it had posted a presentation titled "Apollo Multi-Asset Prime Securities (AMAPS) Overview Presentation" to the Investor Relations section of its website at ir.apollo.com.

Trex Company, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on August 24, 2026, disclosing the appointment of Brian J. Taylor as Senior Vice President and Chief Commercial Officer, effective August 24, 2026.

Capricor Therapeutics, Inc. filed a Form 8-K on August 24, 2026, disclosing that the FDA extended the PDUFA target action date for its Deramiocel Biologics License Application from August 22, 2026 to November 22, 2026, after classifying a recent submission as a major amendment.